First National Trust Co Has $4.50 Million Stake in Cardinal Health, Inc. (NYSE:CAH)

First National Trust Co decreased its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 10.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,014 shares of the company's stock after selling 4,628 shares during the period. First National Trust Co's holdings in Cardinal Health were worth $4,496,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Frazier Financial Advisors LLC grew its position in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock valued at $28,000 after purchasing an additional 104 shares in the last quarter. Promus Capital LLC bought a new position in Cardinal Health in the fourth quarter valued at $30,000. AM Squared Ltd bought a new position in Cardinal Health in the third quarter valued at $33,000. Kentucky Trust Co bought a new position in Cardinal Health in the fourth quarter valued at $41,000. Finally, HHM Wealth Advisors LLC grew its position in Cardinal Health by 57.6% in the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after purchasing an additional 144 shares in the last quarter. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Up 0.5 %

Shares of NYSE CAH traded up $0.63 during mid-day trading on Wednesday, reaching $132.09. 1,364,395 shares of the company were exchanged, compared to its average volume of 1,967,222. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $133.12. The company's 50-day simple moving average is $126.75 and its 200-day simple moving average is $119.69. The stock has a market capitalization of $31.91 billion, a P/E ratio of 24.64, a P/E/G ratio of 1.49 and a beta of 0.66.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is 37.69%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CAH. Morgan Stanley raised their target price on shares of Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research report on Friday, January 31st. Mizuho started coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 price objective for the company. Bank of America raised shares of Cardinal Health from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective for the company in a research report on Tuesday, January 7th. Finally, Argus set a $148.00 price objective on shares of Cardinal Health in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.